Seed VC · Graefelfing, Germany
Medical Strategy - Biotech Investors is a German-based asset management firm specializing in investments within the biotechnology and healthcare sectors. Established in 2001, the company focuses on managing equity funds that invest in innovative biotech and pharmaceutical companies globally. Medical Strategy is recognized for its in-depth scientific expertise and rigorous research-driven approach, enabling it to identify promising growth opportunities in the life sciences industry. The firm has built a strong reputation among institutional and private investors for its consistent performance and sector-specific knowledge, with its headquarters located in Gräfelfing, near Munich, Germany.
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Medical Strategy - Biotech Investors writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. Claude Fundraiser tracks Medical Strategy - Biotech Investors alongside 45,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. Claude scores it on the 8 dimensions VCs read for and ranks the 45,000+ active investors in the database by fit. Medical Strategy - Biotech Investors is one of them — and we'll tell you exactly where they sit in your top 100.